A Six-Week, Parallel, Randomized, Double-Blind Study Comparing the Efficacy and Safety of the 0.5% Timolol/2.0% MK-507 Combination B.I.D. to the Concomitant Administration of 0.5% Timolol B.I.D. and 2.0% MK-507 B.I.D.

Journal

Journal of Ocular Pharmacology and Therapeutics

Journal Volume

19

Journal Issue

5

Pages

417-423

Date Issued

2003

Author(s)

Chen Y.-F.

Hung P.T.

DOI

10.1089/108076803322472980

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0142213556&doi=10.1089%2f108076803322472980&partnerID=40&md5=cdb377f044c7b56cd090917c5bdd1018

https://scholars.lib.ntu.edu.tw/handle/123456789/615190

Publisher

Mary Ann Liebert Inc.

Type

journal article